|
|
|
29.05.26 - 19:06
|
′Hardware is sexy again′: Plug and Play CEO says AI boom has finally fulfilled his 2006 semiconductor dream (Digitimes)
|
|
|
The building where Saeed Amidi runs his global venture empire was once one of the most important semiconductor facilities on the West Coast. Philips Electronics operated a fabrication plant here in Sunnyvale, California, employing 8,000 people at its peak. Then, like much of America's chip manufacturing base, it moved to Asia — to Taiwan, to Korea, to the supply chains that would come to define the global electronics industry for the next three decades....
|
|
|
|
|
|
|
29.05.26 - 12:54
|
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026 (GlobeNewswire EN)
|
|
|
ZUG, Switzerland, May 29, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced the acceptance of one abstract for oral presentation and seven abstracts for flash talk/poster presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2026, to be held from June 12-15, 2026, in Istanbul, Turkey....
|
|
|
29.05.26 - 11:42
|
Observe Medical ASA - Annual General Meeting held (Cision)
|
|
|
Oslo, 29 May 2026
The annual general meeting of Observe Medical ASA (the "Company" or "Observe Medical", Euronext Expand ticker "OBSRV") was held today, on 29 May 2026 at 10:00 hours (CEST), at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway.
All resolutions were made in accordance with the proposals from the board of directors and the nomination committee.
A copy of the signed minutes from the Annual General Meeting of Observe Medical ASA is attached.
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading...
|
|
|
|
|
|
|
|
|
|
|
28.05.26 - 14:06
|
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June (GlobeNewswire EN)
|
|
|
NAARDEN, the Netherlands and MIAMI, May 28, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that company management will participate in the following upcoming investor conferences:...
|
|
|
28.05.26 - 10:24
|
QIAGEN Buy (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Qiagen mit einem Kursziel von 43 US-Dollar auf "Buy" belassen. Das Interesse der Investoren habe vor allem dem Tuberkulosetest QuantiFERON gegolten, schrieb Jan Koch in seinem ......
|
|
|
28.05.26 - 09:00
|
arGEN-X Overweight (DPA-AFX)
|
|
|
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Argenx nach einer Roadshow mit der neuen Chefin Karen Massey mit einem Kursziel von 900 Euro auf "Overweight" belassen. Der Fokus des Antikörperspezialisten liege ......
|
|
|
28.05.26 - 07:03
|
argenx to Host Myositis R&D Webinar on June 23, 2026 (GlobeNewswire EN)
|
|
|
May 28, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled “R&D Spotlight: Advancing FcRn Leadership into Autoimmune Myositis” on Tuesday, June 23, 2026, at 2:00pm ET....
|
|
|
27.05.26 - 13:45
|
arGEN-X Outperform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Argenx nach einem Unternehmensbesuch mit einem Kursziel von 890 US-Dollar auf "Outperform" belassen. Der Antikörperspezialist äußere sich optimistisch hinsichtlich laufender ......
|
|
|
27.05.26 - 07:03
|
argenx to Present at Upcoming Investor Conferences (GlobeNewswire EN)
|
|
|
May 27, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in June:...
|
|
|
26.05.26 - 20:06
|
SpaceX IPO Sends Space Stocks Soaring | Open Interest 5/26/2026 (Bloomberg)
|
|
|
Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Markets are higher as hopes for a peace deal between the US and Iran overshadowed military strikes in the Persian Gulf. Eli Lilly makes a nearly $4 billion vaccine push and reports promising cholesterol drug results. Plus, SpaceX's IPO roadshow is sending space stocks soaring, and Ferrari's first $640,000 EV draws major backlash from fans. (Source: Bloomberg)...
|
|
|
26.05.26 - 16:42
|
AutoZone & Ferrari Slide; Eli Lilly Announces Acquisitions | Stock Movers (Bloomberg)
|
|
|
On this episode of Stock Movers:
- AutoZone (AZO) shares fall after the retailer of automotive replacement parts posted comparable sales for the third quarter that fell short of Wall Street's expectations.
- Ferrari (RACE IM) shares fell almost 8% after critics panned the look of its first fully electric vehicle, a setback for the Italian super-car maker's controversial push into EVs.
- Eli Lilly (LLY) agreed to buy three vaccine developers for as much as $3.8 billion, marking the drugmaker's re-entry into the infectious disease space. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
